SUSAN SULESKE: Open Payments
NPI 1982928735 · MADISON, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$724 in 36 payments from 12 companies in 2025. Trend: 2023 $599 · 2024 $941 · 2025 $724
Food & beverage: $724
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 9 | $164 |
| Novo Nordisk Inc | 7 | $135 |
| ABBVIE INC. | 5 | $107 |
| AstraZeneca Pharmaceuticals LP | 3 | $51 |
| Lilly USA, LLC | 2 | $44 |
| Amgen Inc. | 2 | $42 |
| IBSA Pharma Inc. | 2 | $42 |
| Verona Pharma, Inc. | 2 | $39 |
| Dexcom, Inc. | 1 | $32 |
| ALK-Abello, Inc | 1 | $28 |
Products named: Ozempic, NURTEC ODT, QULIPTA, PREVNAR 20, UBRELVY, MOUNJARO, OTEZLA, Tirosint.
Industry payments across VA — which companies pay providers there.
